Showing 281 - 300 results of 497 for search '"Фармакоэкономика"', query time: 0.04s Refine Results
  1. 281
    DEVELOPMENT OF A COMPUTER MODULE FOR FORECASTING AND ESTIMATING EFFICIENCY OF BASIC THERAPY OF MULTIPLE SCLEROSIS

    DEVELOPMENT OF A COMPUTER MODULE FOR FORECASTING AND ESTIMATING EFFICIENCY OF BASIC THERAPY OF MULTIPLE SCLEROSIS by F. A. Khabirov, D. Kh. Shakirova, O. A. Dun, T. I. Khaibullin

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 282
    PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSSIAN FEDERATION

    PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSS... by V. G. Serpik, R. I. Yagudina

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 283
    Health technology assessment and reimbursement of pharmaceuticals in Italy

    Health technology assessment and reimbursement of pharmaceuticals in Italy by F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan

    Published 2019-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 284
    Patient registers and account registries of compulsory medical insurance: integration and replaceability

    Patient registers and account registries of compulsory medical insurance: integration and replaceability by I. A. Zheleznyakova, G. I. Pirova, E. A. Proxorovich

    Published 2019-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 285
    Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market

    Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market by I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova

    Published 2024-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 286
    A clinical case of ectopic pregnancy with localization in the liver

    A clinical case of ectopic pregnancy with localization in the liver by A. Е. Voynovskiy, О. A. Zaitseva, A. G. Solopova, D. V. Blinov, М. P. Malykh-Bakhtina, G. К. Bykobshchenko

    Published 2024-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 287
    The concept of syndromic diagnoses of osteoarthritis and back pain as a cause of therapy failure

    The concept of syndromic diagnoses of osteoarthritis and back pain as a cause of therapy failure by M. V. Putilina, N. V. Teplova, O. S. Gerasimova

    Published 2021-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 288
    INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW

    INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW by D. G. Tolkacheva, A. V. Torgov, A. S. Margazova

    Published 2018-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 289
    Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system

    Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system by I. Yu. Torshin, A. М. Lila, O. A. Limanova, O. A. Gromova

    Published 2020-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 290
    Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression

    Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression by D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin

    Published 2023-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 291
    The pharmacoeconomic efficacy of chemotherapy for malignant neoplasms of the bronchus and lung

    The pharmacoeconomic efficacy of chemotherapy for malignant neoplasms of the bronchus and lung by S. K. Yarovoy, I. B. Shikina

    Published 2020-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 292
    GENDER FEATURES OF THE POPULATION'S ATTITUDE TO MEDICINES

    GENDER FEATURES OF THE POPULATION'S ATTITUDE TO MEDICINES by N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka

    Published 2016-09-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 293
    Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer

    Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer by O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova

    Published 2021-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 294
    Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation

    Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation by M. V. Zhuravleva, K. A. Kokushkin, E. A. Luchinin, E. V. Luchinina, T. R. Kameneva, E. V. Kuznetsova, V. S. Krysanova, E. V. Makarova, L. G. Zhukova

    Published 2024-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 295
    PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY

    PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY by A. V. Rudakova, S. A. Protsenko, I. A. Koroleva

    Published 2017-08-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 296
    PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA

    PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA by A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 297
    PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION

    PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION by M. Yu. Frolov, V. A. Rogov

    Published 2016-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 298
    Development of the system of state financing of Compulsory Health Insurance

    Development of the system of state financing of Compulsory Health Insurance by А. V. Larionov, S. V. Russkikh, S. V. Maslennikov

    Published 2022-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 299
    Crucial areas of the economic analysis of public cancer care

    Crucial areas of the economic analysis of public cancer care by D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova

    Published 2020-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 300
    Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma

    Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma by S. K. Zyryanov, K. V. Orlova

    Published 2024-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: